A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial was to demonstrate the efficacy of a 400 μg dose strength of
intranasal fentanyl spray (INFS, Instanyl®) and to evaluate the safety and to establish long
term tolerability of treatment with INFS doses of 50, 100, 200 and 400 μg.